Sihuan Pharmaceutical
(OTC: SHPHY)
|
n.a., n.a. | |||
---|---|---|---|---|
Last: $n/a | Change: n/a | %Change: n/a | Volume: 0 |
Open: | $ 2.67 | Volume: | 0 | |
---|---|---|---|---|
High: | $ 2.67 | Yield(%) | 0.00 | |
Low: | $ 2.67 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 559.21M | |
EPS ($) | 1.54 | Shares Out: | 232.04M |
% Price Change (last 4 weeks): | -11.56 |
---|---|
% Price Change (last 13 weeks): | -13.62 |
% Price Change (last 26 weeks): | -24.80 |
% Price Change (last 52 weeks): | -67.14 |
% Price Change (year to date): | -67.14 |
Return on Equity (%): | -1.17 |
---|---|
Return on Assets (%): | -0.45 |
Return on Invested Capital (%): | -8.37 |
Gross Profit Margin (%): | 65.85 |
---|---|
Net Profit Margin (%): | -2.90 |
Operating Profit Margin (%): | -10.39 |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.
|
Sihuan Pharmaceutical
22nd floor, Building 4 Zhubang 2000 Business Centre West Balizhuang, Chaoyang District Beijing BE 100025 Phone: 86.10.52278700 Fax: 86.10.52278758 http://www.sihuanpharm.com |
Earnings (1year) ($): | -0.03 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 2.69 |
Cash Flow ($): | 0.10 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 6.49 |
Price/Book (x): | 2.72 |
Price/Cash Flow (x): | 39.51 |
Quick Ratio (x): | 1.35 |
---|---|
Current Ratio (x): | 1.51 |
LT Debt/Equity (x): | 21.87 |
Total Debt/Equity (x): | 28.63 |